Neil Skolnik, MD
Family Medicine · Jenkintown, PANPI 1275564619
Payments from drug & device makers
Across 794 payments — averaging $1138.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$278K
- GSK$161K
- Lilly USA, LLC$100K
- Boehringer Ingelheim$75K
- Eli Lilly$70K
- Novo Nordisk$41K
- plus $179K from 19 others
Across 4 payments — averaging $2123.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$5K
- Sanofi-aventis U.S. LLC$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 265 | $278,309 |
| GSK | 121 | $161,234 |
| Lilly USA, LLC | 93 | $99,795 |
| Boehringer Ingelheim | 70 | $74,831 |
| Eli Lilly | 87 | $70,358 |
| Novo Nordisk | 25 | $40,885 |
| Bayer | 29 | $30,467 |
| Astrazeneca AB | 10 | $25,309 |
| Sanofi-aventis U.S. LLC | 18 | $25,214 |
| Sanofi | 12 | $20,516 |
| Astrazeneca UK Limited | 10 | $14,406 |
| Teva Pharmaceuticals USA, Inc. | 4 | $13,855 |
| Astellas Pharma US Inc | 6 | $9,100 |
| Insulet Corporation | 14 | $7,612 |
| Embecta Corp. | 3 | $5,647 |
| Abbott | 5 | $4,963 |
| Merck | 6 | $4,634 |
| Sanofi Pasteur Inc. | 4 | $4,416 |
| Viiv Healthcare Company | 2 | $4,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,640 |
| Novartis | 2 | $2,572 |
| Azurity Pharmaceuticals, Inc. | 2 | $1,688 |
| Boehringer Ingelheim International GmbH | 1 | $975 |
| Regeneron Healthcare Solutions, Inc. | 3 | $798 |
| Mannkind Corporation | 1 | $59 |
How this compares
$904,281 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Jenkintown
- John RussellJenkintown$82K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.